Akero Therapeutics (NasdaqGS:AKRO) FY Conference Transcript

Akero Therapeutics (NasdaqGS:AKRO) FY Conference September 08, 2025 10:45 AM ET Company ParticipantsAndrew Cheng - President, CEO & DirectorMichael Ulz - Executive Director - Biotechnology Equity ResearchMichael UlzGood morning, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Goldsmith, a biotech analyst here, and it's my pleasure to introduce Andrew Cheng, CEO from Akero Therapeutics. Before we get started, I just need to read a quick disclaimer for importan ...